Log in to save to my catalogue

700 Increasing MHC-I expression to potentiate immune checkpoint blockade therapy

700 Increasing MHC-I expression to potentiate immune checkpoint blockade therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bab53d3c27fa4f8ba5c795696a9cf58b

700 Increasing MHC-I expression to potentiate immune checkpoint blockade therapy

About this item

Full title

700 Increasing MHC-I expression to potentiate immune checkpoint blockade therapy

Publisher

London: BMJ Publishing Group Ltd

Journal title

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A728-A728

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

BackgroundCancer immunotherapy, especially immune checkpoint blockade (ICB) therapy, is leading to a paradigm shift in cancer treatment, as a small percentage of cancer patients have obtained durable remission following ICB treatment. Successful ICB responses rely on cancer cells presenting antigens to the cell surface via the major histocompatibil...

Alternative Titles

Full title

700 Increasing MHC-I expression to potentiate immune checkpoint blockade therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_bab53d3c27fa4f8ba5c795696a9cf58b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bab53d3c27fa4f8ba5c795696a9cf58b

Other Identifiers

E-ISSN

2051-1426

DOI

10.1136/jitc-2021-SITC2021.700

How to access this item